Antares Therapeutics
Ewing, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $177M
Overview
A leader in developing and commercializing patient-friendly auto-injector devices for partnered pharmaceutical products.
Drug DeliveryEndocrinologyRheumatology
Technology Platform
Proprietary auto-injector and pen device platforms (e.g., VIBEX®) designed for safe, simple, and convenient self-administration of injectable pharmaceuticals.
Funding History
1Total raised:$177M
Venture$177M
Opportunities
Growth driven by the expanding market for self-administered biologics and biosimilars requiring user-friendly delivery.
Risk Factors
Revenue concentration risk from a limited number of partnership agreements and competition from alternative delivery technologies.
Competitive Landscape
A established competitor in the drug delivery device space, vying with companies like Ypsomed for pharmaceutical partnership deals.